Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Antidepressants used for treatment of depression exert their efficacy by blocking reuptake at serotonin transporters (5-HTT) and/or norepinephrine transporters (NET). Recent studies suggest that serotonin and norepinephrine reuptake inhibitors that block both 5-HTT and NET have better tolerability than tricyclic antidepressants and may have higher efficacy compared to selective serotonin reuptake inhibitors. Previous positron emission tomography (PET) studies have reported >80% 5-HTT occupancy with clinical doses of antidepressants, but there has been no report of NET occupancy in patients treated with antidepressants. In the present study, we investigated both 5-HTT and NET occupancies by PET using radioligands [11C]DASB and (S,S)-[18F]FMeNER-D2, in six patients, each with major depressive disorder (MDD), using various doses of milnacipran. Our data show that mean 5-HTT occupancy in the thalamus was 33.0% at 50 mg, 38.6% at 100 mg, 60.0% at 150 mg and 61.5% at 200 mg. Mean NET occupancy in the thalamus was 25.3% at 25 mg, 40.0% at 100 mg, 47.3% at 125 mg and 49.9% at 200 mg. Estimated ED50 was 122.5 mg with the dose for 5-HTT and 149.9 mg for NET. Both 5-HTT and NET occupancies were observed in a dose-dependent manner. Both 5-HTT and NET occupancies were about 40% by milnacipran at 100 mg, the dose most commonly administered to MDD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationPapakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308 · cited 6×
“Although TCAs have equivalent or in some reports higher responder rates (Anderson, 1998) than SSRIs, their use is limited because of poor tolerability due to the wide interaction with various receptors, such as a-adrenergic receptors, muscarinic cholinergic receptors and H1-histamine receptors.”
BackgroundInfluentialHoule, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000365 · Cited by 276 · cited 1×
“A previous report suggested that the thalamus has the highest specific binding for 5-HTT in the brain (Houle et al. 2000).”
BackgroundCannon, D. M., Ichise, M., Rollis, D., Klaver, J. M., Gandhi, S. K., Charney, D. S., Manji, H. K., & Drevets, W. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.016 · Cited by 219
Regional distribution of serotonin transporter protein in postmortem human brain
Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.10.001 · Cited by 179
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
Vaishnavi, S. N., Nemeroff, C. B., Plott, S. J., Rao, S. G., Kranzler, J., & Owens, M. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.006 · Cited by 178 · cited 6×
“…the two transporters [e.g. Ki=8.44/22 nM (Vaishnavi et al. 2004), 123/200 nM (Koch et al. 2003) ; 5-HTT/NET], whereas duloxetine [e.g. Ki=0.07/1.17 (Vaishnavi et al. 2004), 0.8/7.5 (Bymaster et al. 2001)] and venlafaxine [e.g. Ki=7.8/1920 (Vaishnavi et al. 2004), 82/2483 (Bymaster et al. 2001)]…”
BackgroundInfluentialA dose-finding study of duloxetine based on serotonin transporter occupancy
Takano, A., Suzuki, K., Kosaka, J., Ota, M., Nozaki, S., Ikoma, Y., Tanada, S., & Suhara, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0304-0 · Cited by 110 · cited 4×
“…or plasma concentration and occupancies of 5-HTT and NET were modelled by the following equation: Occu=100rC= ED50+CÞ,ð where C is the dose or plasma concentration of milnacipran, and ED50 is the dose or plasma concentration required to induce 50% occupancy (Suhara et al. 2003; Takano et al. 2006).”
BackgroundMethodSelf-citation
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Auclair, A. L., Martel, J. C., Assié, M. B., Bardin, L., Heusler, P., Cussac, D., Marien, M., Newman-Tancredi, A., O'Connor, J. A., & Depoortère, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.024 · Cited by 263
Arakawa, R., Stenkrona, P., Takano, A., Svensson, J., Andersson, M., Nag, S., Asami, Y., Hirano, Y., Halldin, C., & Lundberg, J. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz003 · Cited by 70
Self-citationMoriguchi, S., Takano, H., Kimura, Y., Nagashima, T., Takahata, K., Kubota, M., Kitamura, S., Ishii, T., Ichise, M., Zhang, M.-R., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx069 · Cited by 47
Self-citation
Metadata
- Authors
- Nogami, T., Takano, H., Arakawa, R., Ichimiya, T., Fujiwara, H., Kimura, Y., Kodaka, F., Sasaki, T., Takahata, K., Suzuki, M., Nagashima, T., Mori, T., Shimada, H., Fukuda, H., Sekine, M., Tateno, A., Takahashi, H., Ito, H., Okubo, Y., & Suhara, T.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-01
- Volume
- 16
- Issue
- 5
- Pages
- 937-943
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2128473988
- Cited by
- 46
- References
- 7
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2. https://app.cochat.ai/papers/10.1017/s1461145712001009
- The paper
- Nogami, T., Takano, H., Arakawa, R., Ichimiya, T., Fujiwara, H., Kimura, Y., Kodaka, F., Sasaki, T., Takahata, K., Suzuki, M., Nagashima, T., Mori, T., Shimada, H., Fukuda, H., Sekine, M., Tateno, A., Takahashi, H., Ito, H., Okubo, Y., & Suhara, T. (2013). Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145712001009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.